Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ellagic acid in multiple sclerosis
IRCT20120415009472N22Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Ellagic acid in multiple sclerosis (MS), sponsored by Iran University of Medical Sciences. Started Jan 2021; status: completed.
02
Drugs
Ellagic acid
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20120415009472N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120415009472N22.